BLLN · BillionToOne, Inc. · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-10-15 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.000 to $98.770 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
900 |
| 2026-10-15 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.270 to $100.250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
1,861 |
| 2026-10-15 | Atay Oguzhan |
Director, See Remarks |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. |
Class A Common Stock
|
5,150 |
| 2026-10-15 | Atay Oguzhan |
Director, See Remarks |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The options are fully vested and exercisable. |
Stock Option (right to buy)
|
5,150 |
| 2026-10-15 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.765 to $102.830 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
133 |
| 2026-10-15 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.270 to $101.200 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
1,276 |
| 2026-10-15 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.370 to $102.140 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
980 |
| 2026-10-14 | Atay Oguzhan |
Director, See Remarks |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The options are fully vested and exercisable. |
Stock Option (right to buy)
|
3,183 |
| 2026-10-14 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on June 7, 2026. Represents shares held by the Reporting Person's spouse. |
Class A Common Stock
(I)
|
2,667 |
| 2026-10-14 | Atay Oguzhan |
Director, See Remarks |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. |
Class A Common Stock
|
3,183 |
| 2026-10-14 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. |
Class A Common Stock
|
100 |
| 2026-10-14 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.000 to $98.990 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
3,083 |
| 2026-10-13 | Lynch Thomas P. |
See Remarks |
Convert↑
|
Class A Common Stock
|
2,000 |
| 2026-10-13 | Lynch Thomas P. |
See Remarks |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025. |
Stock Option (right to buy)
|
2,000 |
| 2026-10-12 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.260 to $94.225 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
6,763 |
| 2026-10-12 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.265 to $95.205 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
3,869 |
| 2026-10-12 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.2596 to $93.255 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
2,553 |
| 2026-10-12 | Atay Oguzhan |
Director, See Remarks |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The options are fully vested and exercisable. |
Stock Option (right to buy)
|
16,667 |
| 2026-10-12 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on June 7, 2026. Represents shares held by the Reporting Person's spouse. |
Class A Common Stock
(I)
|
2,667 |
| 2026-10-12 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.250 to $92.170 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
1,961 |
| 2026-10-12 | Atay Oguzhan |
Director, See Remarks |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. |
Class A Common Stock
|
16,667 |
| 2026-10-12 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.945 to $96.765 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
1,521 |
| 2026-10-08 | Lynch Thomas P. |
See Remarks |
Convert↑
|
Class A Common Stock
|
8,000 |
| 2026-10-08 | Lynch Thomas P. |
See Remarks |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025. |
Stock Option (right to buy)
|
8,000 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.7354 to $108.710 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
4,284 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The options are fully vested and exercisable. |
Stock Option (right to buy)
|
10,000 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.010 to $107.970 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
2,200 |
| 2026-10-05 | ten Bosch John Roderick |
See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. |
Class A Common Stock
|
1,417 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. |
Class A Common Stock
|
10,000 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.505 to $106.350 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
866 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.040 to $109.500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
1,829 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.880 to $105.720 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
555 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. |
Class A Common Stock
|
100 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. |
Class A Common Stock
|
10,000 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.730 to $107.700 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
1,909 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.040 to $109.030 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
4,916 |
| 2026-10-05 | ten Bosch John Roderick |
See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. |
Class A Common Stock
|
1,417 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.740 to $109.480 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
2,921 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.890 to $106.180 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
400 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The options are fully vested and exercisable. |
Stock Option (right to buy)
|
10,000 |
| 2026-10-05 | Tsao David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. |
Class A Common Stock
|
20 |
| 2026-09-28 | Atay Oguzhan |
Director, See Remarks |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. |
Class A Common Stock
|
8,333 |
| 2026-09-28 | Atay Oguzhan |
Director, See Remarks |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The options are fully vested and exercisable. |
Stock Option (right to buy)
|
8,333 |
| 2026-09-28 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on June 7, 2026. Represents shares held by the Reporting Person's spouse. |
Class A Common Stock
(I)
|
2,666 |
| 2026-09-28 | Atay Oguzhan |
Director, See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. |
Class A Common Stock
|
8,333 |
| 2026-09-24 | Tsao David |
Director, Chief Technology Officer |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. |
Class A Common Stock
|
3,333 |
| 2026-09-24 | Tsao David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. |
Class A Common Stock
|
3,333 |
| 2026-09-24 | ten Bosch John Roderick |
See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. |
Class A Common Stock
|
1,416 |
| 2026-09-24 | Tsao David |
Director, Chief Technology Officer |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The options are fully vested and exercisable. |
Stock Option (right to buy)
|
3,333 |
| 2026-09-21 | ten Bosch John Roderick |
See Remarks |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. |
Class A Common Stock
|
1,416 |